Ubisoft: Caution!
NEUTRAL, Fair Value EUR15.5 (-14%)
SGS SA: Still active in M&A
BUY, Fair Value CHF2150 (+28%)
Adocia: New phase Ib start with BC lispro
BUY, Fair Value EUR113 (+52%)
ASK: Disappointing H1 results but better outlook for H2
CORPORATE, Fair Value EUR2.4 vs. EUR5 (+46%)
ASML ships the new NXT1980Di
NEUTRAL, Fair Value EUR77 (+4%)
Innate Pharma: Brace yourselves… AZN is coming (back)!
BUY Coverage initiated, Fair Value EUR19 (+44%)
Novo Nordisk: How competitive will all degludec-based products be in the US?
NEUTRAL, Fair Value DKK390 (+5%)
ERYTech: H1 15 loss higher than expected. But towards a US listing and the frontline setting in ALL… What else ?
BUY, Fair Value EUR42 (+25%)
Dialog Semiconductor: Cypress drops bid for Atmel
NEUTRAL, Fair Value EUR39 (+8%)